Your browser doesn't support javascript.
loading
Longitudinal associations between pain and substance use disorder treatment outcomes.
Ferguson, Erin; Lewis, Ben; Teitelbaum, Scott; Reisfield, Gary; Robinson, Michael; Boissoneault, Jeff.
Afiliação
  • Ferguson E; Department of Clinical and Health Psychology, University of Florida, Gainesville, FL, USA; Center for Pain Research and Behavioral Health, University of Florida, Gainesville, FL, USA.
  • Lewis B; Department of Psychiatry, University of Florida, Gainesville, FL, USA.
  • Teitelbaum S; Department of Psychiatry, University of Florida, Gainesville, FL, USA.
  • Reisfield G; Department of Psychiatry, University of Florida, Gainesville, FL, USA.
  • Robinson M; Department of Clinical and Health Psychology, University of Florida, Gainesville, FL, USA; Center for Pain Research and Behavioral Health, University of Florida, Gainesville, FL, USA.
  • Boissoneault J; Department of Clinical and Health Psychology, University of Florida, Gainesville, FL, USA; Center for Pain Research and Behavioral Health, University of Florida, Gainesville, FL, USA. Electronic address: jboissoneault@phhp.ufl.edu.
J Subst Abuse Treat ; 143: 108892, 2022 12.
Article em En | MEDLINE | ID: mdl-36228338
ABSTRACT

INTRODUCTION:

Pain is commonly reported among those in treatment for substance use disorders (SUD) and is associated with poorer SUD treatment outcomes. The current study examined the trajectory of pain over the course of SUD treatment and associations with substance use outcomes.

METHODS:

This observational study included adults seeking treatment for alcohol, cannabis, or opioid use disorders (N = 811). Participants completed a battery of assessments at treatment admission, 30 days post admission, and at discharge, including measures of demographics, pain, quality of life, abstinence self-efficacy, and craving.

RESULTS:

Analyses indicated linear reductions in pain intensity and interference over time. Significant interactive effects were observed for opioid use disorder (OUD) and time, such that participants with OUD had greater reductions in pain intensity and interference over time compared to those without OUD. Elevated pain intensity was associated with negative treatment outcomes, including reduced quality of life and abstinence self-efficacy, and greater craving and negative affect.

CONCLUSIONS:

Reductions in pain occur over the course of SUD treatment, particularly for those with OUD. Greater pain was also associated with adverse SUD treatment outcomes. Results suggest that treatment and associated abstinence may be beneficial for those with co-occurring pain and SUD, highlighting an additional benefit of improving access to SUD treatment for patients and health care systems. Future research should replicate these findings among diverse samples and further characterize the trajectory of pain during and after SUD treatment.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Base de dados: MEDLINE Assunto principal: Transtornos Relacionados ao Uso de Substâncias / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Observational_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Adult / Humans Idioma: En Revista: J Subst Abuse Treat Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Base de dados: MEDLINE Assunto principal: Transtornos Relacionados ao Uso de Substâncias / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Observational_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Adult / Humans Idioma: En Revista: J Subst Abuse Treat Ano de publicação: 2022 Tipo de documento: Article